Medicxi Ventures Management (Jersey) Ltd
CIK
1715579
Location
ST. HELIER, Y9
Portfolio Value
Small
$981,805,432
Diversification
Highly concentrated
Filing Date
Global Rank
#1,525
/ 8,232
▲ 439
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+38.5%
Period ended 2 months ago
Filed Apr 21, 2026 · 54d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+299.2%
SPY
+76.3%
Annualised alpha
+37.8%
Max drawdown
−47.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
4 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
80.8%
+13.3 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
6,674
Highly concentrated+1,657
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $981,805,432 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | −195,383 | 2,674,182 | $85,600,565 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
4 positions ·
$981,805,432 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Held | 19,963,157 | $792,936,596 | 80.76% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 2,674,182 | $85,600,565 | 8.72% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 7,464,572 | $82,931,394 | 8.45% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
Held | 3,039,892 | $20,336,877 | 2.07% |